Scrying Biotech
Long only, biotech, micro-cap, small-cap

Nektar Fortifies Its Position In Advance Of The Rescheduled FDA Panel On OIC

When I author an opinion piece, I like to keep my followers updated on important changes in the company's fortunes, or to my investment thesis if they occur within a 3-month time frame by expressing thoughts in the comments section of that article. This, however, is not always adequate to the task at hand, and that is now the case where Nektar (NASDAQ:NKTR) is concerned.

I would dearly love to refer you back to that piece, but it's now embargoed for Seeking Alpha Pro readers only. Suffice it to say that Nektar is a burgeoning powerhouse in biotechnology as it morphs from a developmental stage company, into a hybrid, income-generating commercial stage venture.

Crucial to its fortunes,...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details